Royalty Pharma
RPRX
#1025
Rank
HK$146.58 B
Marketcap
HK$248.79
Share price
0.69%
Change (1 day)
9.55%
Change (1 year)

Earnings for Royalty Pharma (RPRX)

Earnings in 2024 (TTM): HK$14.97 Billion

According to Royalty Pharma's latest financial reports the company's current earnings are HK$2.26 Billion. In 2023 the company made an earning of HK$14.70 Billion, an increase over its 2022 earnings that were of HK$3.25 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Royalty Pharma from 2019 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) HK$14.97 B1.85%
2023 HK$14.70 B351.47%
2022 HK$3.25 B-70.3%
2021 HK$10.96 B-24.3%
2020 HK$14.48 B-31.9%
2019 HK$21.26 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-HK$58.45 Million-100.39%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$52.79 B 252.83%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$79.06 B 428.38%๐Ÿ‡บ๐Ÿ‡ธ USA